NVAX

Q: What is the price of Novavax (NVAX) today?

The price of Novavax (NVAX) today is R$ 40,65, with a variation of -34.84% compared to the last year. The price of Novavax (NVAX) started the year trading around R$ 43,58 and today it is at R$ 40,65. Follow the real-time price chart, the historical price of Novavax (NVAX), and stock data from Ibovespa and international markets.

Q: When does Novavax (NVAX) pay dividends?

Novavax (NVAX) did not distribute dividends in the last year.

Q: Novavax (NVAX) is it worth it?

Currently, Novavax (NVAX) is priced at R$ 40,65, with a P/E of 3,00%, representing a deviation of -2,52% from its historical average P/E. In the last year, the stock showed a variation of -34.84% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -34,84%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Novavax (NVAX)?

Investing in shares of Novavax (NVAX) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Novavax (NVAX) yield today?

The yield of Novavax (NVAX) was 0,40% in the last month, -34,84% in the last year and -93,04% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of Novavax (NVAX) today, the total investment would be based on the current price of R$ 40,65.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 2.648,75In 5 years: R$ 282,92In 10 years: 141,46It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Novavax Inc.

Price

US$ 7,50

variation (12m)

-34,84%

p/l

3,00

p/vp

33,76

DIVIDEND YIELD

0,00%

quote NVAX

BVMF

NVAX

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of NVAX

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

0,40%

3 months

8,38%

1 year

-34,84%

2 years

-10,18%

5 years

-93,04%

10 years

-96,52%

real profitability

profitability minus inflation.

1 month

0,40%

3 months

7,84%

1 year

-38,09%

2 years

-18,13%

5 years

-94,91%

10 years

-97,94%

Indicators NVAX

check out the fundamentals of Novavax shares

P/L

3,00

Sector: -3,27 Industry: -3,27

P/SALES (PSR)

1,22

Sector: -3,77 Industry: -3,77

P/VP

33,76

Sector: 1,74 Industry: 1,74

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

31,64%

Sector: -63,50% Industry: -63,50%

ROE

1.123,95%

Sector: -67,23% Industry: -67,23%

ROIC

59,38%

Sector: -2.087,74% Industry: -2.087,74%

Net Margin

40,72%

Sector: -43,34% Industry: -43,34%

GROSS MARGIN

87,80%

Sector: 40,50% Industry: 40,50%

OPERATING MARGIN

33,85%

Sector: -43,21% Industry: -43,21%

P/EBITDA

2,56

Sector: -3,13 Industry: -3,13

P/EBIT

2,79

Sector: -3,41 Industry: -3,41

P/ASSETS

0,95

Sector: 1,29 Industry: 1,29

VPA

0,23

Sector: 1,80 Industry: 1,80

LPA

2,61

Sector: -2,09 Industry: -2,09

EQUITY / ASSETS

0,03

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

16,90%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0,00%

Sector: - Industry: -

FAIR PRICE OF Novavax ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 7,50

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-51,00%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

NVAX indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
JNJ	19,04	5,50	28,88%	2,80%	US$ 431,37 B	25,00%
PFE	13,45	1,62	12,08%	6,68%	US$ 144,63 B	16,84%
ABBV	79,66	228,58	286,94%	3,38%	US$ 334,19 B	7,31%
NVO	15,51	9,75	62,86%	2,83%	US$ 253,39 B	35,63%
MRK	13,05	4,36	33,44%	3,75%	US$ 214,13 B	25,79%
BMY	19,31	5,58	28,87%	5,13%	US$ 97,52 B	10,58%
GILD	22,64	7,29	32,21%	2,72%	US$ 142,89 B	21,87%
AZN	30,26	5,60	18,51%	1,91%	US$ 251,01 B	14,68%
ZTS	26,68	14,00	52,48%	1,19%	US$ 69,70 B	27,83%
HALO	15,59	26,12	167,47%	0,00%	US$ 8,69 B	47,28%
REGN	13,88	2,07	14,89%	0,30%	US$ 61,90 B	31,37%
AMGN	23,87	21,27	89,11%	3,15%	US$ 158,02 B	18,96%
VRTX	27,92	5,91	21,18%	0,00%	US$ 101,55 B	31,86%
ADMA	20,53	10,77	52,45%	0,00%	US$ 4,29 B	44,06%
MCK	27,24	-99,86	-366,63%	0,41%	US$ 86,18 B	0,84%
BIIB	13,38	1,16	8,68%	0,00%	US$ 20,48 B	15,31%
CAH	22,58	-13,38	-59,26%	1,37%	US$ 35,25 B	0,70%

comparison of NVAX with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history NVAX dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Novavax

Novavax Inc.

Average user rating I10

4.0 (4 people)

Estados Unidos

38 years

Foundation: 1987

1995

Year of debut on the stock exchange - 30 years

791

Employees

The Company Novavax Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 1,27 Billion, having a net worth of $ 37,62 Milhões.

With a total of 791 employees, the company is listed in the sector of Cuidados de saúde and categorized in industry of Biotecnologia.

In the last 12 months the Company had a revenue of $ 1,04 Billion, which generated a profit in the amount of $ 422,83 Milhões.

As for its main indicators, the Company has a P/E ratio of 3,00, a P/B ratio of 33,76 and in the last 12 months the Company did not pay dividends.

The Company is traded through the ticker NVAX.

Market value

US$ 1,27 Billion

Net worth

US$ 37,62 Milhões

US$ 37.620.000,00

Assets

US$ 1,34 Billion

US$ 1.336.550.000,00

Total Number of Shares

162,00 Milhões

162.000.000

Average Daily Trading Volume

US$ 6,51 Milhões

US$ 6.506.185,56

Sector

Cuidados de saúde

Industry

Biotecnologia

NVAX

NVAX revenue and profits

NVAX results

DRAG THE FRAME TO SEE MORE DATA

NVAX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12 M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12 M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12 M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12 M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12 M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12 M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12 M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

Common Questions

What is the price of Novavax (NVAX) today?

The price of Novavax (NVAX) today is R$ 40,65, with a variation of -34.84% compared to the last year. The price of Novavax (NVAX) started the year trading around R$ 43,58 and today it is at R$ 40,65. Follow the real-time price chart, the historical price of Novavax (NVAX), and stock data from Ibovespa and international markets.

When does Novavax (NVAX) pay dividends?

Novavax (NVAX) did not distribute dividends in the last year.

Novavax (NVAX) is it worth it?

Currently, Novavax (NVAX) is priced at R$ 40,65, with a P/E of 3,00%, representing a deviation of -2,52% from its historical average P/E. In the last year, the stock showed a variation of -34.84% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -34,84%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Novavax (NVAX)?

Investing in shares of Novavax (NVAX) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Novavax (NVAX) yield today?

The yield of Novavax (NVAX) was 0,40% in the last month, -34,84% in the last year and -93,04% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of Novavax (NVAX) today, the total investment would be based on the current price of R$ 40,65.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 2.648,75
In 5 years: R$ 282,92
In 10 years: 141,46

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NVAX

Novavax Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of NVAX

check out the fundamentals of Novavax shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Novavax

Novavax Inc.

Estados Unidos

38 years

1995

791

PROFIT X PRICE NVAX

NVAX results

NVAX cash flow

evolution of assets - NVAX

NVAX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80